Synthetic Inhibitors of CDK4/6 Activities and Tumor Suppression: A Preface to the Special Issue
The status of RB1 in cancer may help us determine the optimal therapeutic approach to patients [...]
2011 ◽
Vol 15
(2)
◽
pp. 6-19
Keyword(s):
2013 ◽
Vol 19
(3)
◽
pp. 405-425
◽
2009 ◽
Vol 4
(3)
◽
pp. 173-174
◽
1971 ◽
Vol 74
(635)
◽
pp. 1602-1607
2000 ◽
Vol 48
(2)
◽
pp. 107-112
◽